Literature DB >> 1692755

High dose caffeine and ventricular arrhythmias.

M G Myers1, L Harris.   

Abstract

The effect of high dose caffeine on ventricular arrhythmias was examined in 35 patients with recent myocardial infarctions. All patients received caffeine 450 mg or placebo on separate days using a randomized double-blind study design. Continuous Holter electrocardiographic recordings were performed for 8 h. Caffeine ingestion did not cause any increase in the frequency or complexity of ventricular ectopy with 19 of 35 patients experiencing ventricular arrhythmias after caffeine compared with 24 of 35 with placebo. Serious ventricular ectopic activity (including ventricular couplets and tachycardia) was similar on both study days. Moderately high doses of caffeine do not appear to increase ventricular arrhythmias in this patient population with ischemic heart disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692755

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  5 in total

Review 1.  European Cardiac Arrhythmia Society Statement on the cardiovascular events associated with the use or abuse of energy drinks.

Authors:  Samuel Lévy; Luca Santini; Alessandro Capucci; Ali Oto; Maurizio Santomauro; Carla Riganti; Antonio Raviele; Riccardo Cappato
Journal:  J Interv Card Electrophysiol       Date:  2019-09-03       Impact factor: 1.900

Review 2.  Selected health and behavioral effects related to the use of caffeine.

Authors:  R J Lamarine
Journal:  J Community Health       Date:  1994-12

Review 3.  Wake up and smell the coffee. Caffeine, coffee, and the medical consequences.

Authors:  T Chou
Journal:  West J Med       Date:  1992-11

4.  Coffee, caffeine, and risk of hospitalization for arrhythmias.

Authors:  Arthur L Klatsky; Amatul S Hasan; Mary Anne Armstrong; Natalia Udaltsova; Cynthia Morton
Journal:  Perm J       Date:  2011

Review 5.  The Safety of Ingested Caffeine: A Comprehensive Review.

Authors:  Jennifer L Temple; Christophe Bernard; Steven E Lipshultz; Jason D Czachor; Joslyn A Westphal; Miriam A Mestre
Journal:  Front Psychiatry       Date:  2017-05-26       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.